Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nitrile Hydrolysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel ion-exchange route for D-calcium pantothenate eliminates water generation, boosting yield and purity for reliable vitamin B5 supply chains.
Novel synthetic route for 3,4-dichloro-2-nitrobenzoic acid via cyanide hydrolysis. High purity, scalable process for API intermediates.
Novel hydrolysis and Hoffman degradation route for high-purity Pentafluoroaniline. Offers significant cost reduction and scalable supply chain solutions for global pharmaceutical and agrochemical manufacturers.
Patent CN103232359A details a mild base-catalyzed nitrile hydrolysis method. This technology offers significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Novel synthesis method for Gadoxetic acid intermediate reduces cost and improves scalability for pharmaceutical manufacturing supply chains significantly.
Patent CN104744288A details a green rhodium-catalyzed nitrile hydrolysis. This method offers significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN114790149A reveals a cost-effective route for 2-chloro-4-fluorobenzoic acid, eliminating precious metals for reliable agrochemical intermediate supply.
Advanced two-step synthesis for 2-phenylpropionic acid ensures high purity and cost efficiency for pharmaceutical intermediate supply chains globally.
Patent CN101914052B reveals a cost-effective oxiracetam synthesis using 3-chloro-2-hydroxy propionitrile, offering high purity and scalable manufacturing for pharmaceutical supply chains.
Novel cuprous-catalyzed method for isocoumarin derivatives. Enhances purity and supply chain reliability for agrochemical manufacturing.
Patent CN103641758A details a cost-effective D,L-methionine preparation using unpurified methional and HCN gas, offering high yield and supply chain advantages.
Patent CN100418953C reveals a novel telmisartan synthesis route eliminating needle crystallization issues, ensuring high purity and cost reduction in pharmaceutical manufacturing.